跳至主要内容
临床试验/NCT06786988
NCT06786988尚未招募不适用

Cerebral Safety After Pulsed-Field Ablation of Atrial Fibrillation

Charles University, Czech Republic0 个研究点目标入组 40 人开始时间: 2025年2月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
主要终点
ischaemic lesion

研究概览

简要总结

A study evaluating the incidence of ischaemic lesions detected by brain MRI scan in subjects undergoing pulsed-field ablation for atrial fibrillation (VARIPULSE system).

详细描述

An observational study evaluating the incidence of ischaemic lesions on brain MRI performed after ablation of atrial fibrillation using the Varipulse catheter.

  1. A baseline MRI scan will be carried out one day before the procedure.
  2. A post-procedure MRI scan will be performed 24-36 hours after the procedure.
  3. A follow-up MRI will be performed within 1 year after the ablation.

Paroxysmal and non-paroxysmal AF patients will be included. Regarding the extent of ablation lesions, pulmonary vein isolation (PVI) will be performed in paroxysmal AF, whereas PVI + left atrial posterior wall ablation will be performed in non-paroxysmal patients. All procedures will be performed under intracardiac echocardiography guidance.

The patients will undergo a neurocognitive evaluation:

  1. One day before the procedure: Montreal Cognitive Assessment (The MoCA Test)
  2. 24-36 hours after the procedure: The National Institutes of Health Stroke Scale (NIHSS)
  3. Up to 1 year after the procedure the MoCA test.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • AF with an indication for ablation

排除标准

  • MRI contraindication

结局指标

主要结局

ischaemic lesion

时间窗: one day before the procedure (the first MRI scan), 24-36 hour sfter the procedure (the second scan) and up to 1 year after the procedure (the third scan)

ischemic lesion on MRI

次要结局

  • Neurocognitive evaluation(one day before the procedure (the first MoCA test) and up to 1 year after the procedure (the second MoCA test))
  • NIHSS score(24-36 hours after the procedure)

研究者

发起方
Charles University, Czech Republic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Marek Hozman, MD, PhD

Interventional electrophysiologist

Charles University, Czech Republic

相似试验